DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 1Olpha
03 6Granules India Limited
04 42care4
05 1Accord healthcare
06 2Adamed Pharma
07 1Alhavi Pharma
08 2Alkem Laboratories
09 1Alter Laboratories Sa
10 2Annora Pharma
11 1Aurobindo Pharma Limited
12 1Bausch Health
13 68Boehringer Ingelheim GmbH
14 3CLONMEL HLTHCARE
15 1Demo S.A.
16 3Grindeks AS
17 3Grupo Azevedos
18 4Intas Pharmaceuticals
19 1Intas Third Party Sales 2005 Sl
20 1InvaGen Pharmaceuticals Inc
21 2Kinapse
22 1Krka
23 3Laboratorios Lafage
24 3MEDOCHEMIE LTD
25 6MSN Laboratories
26 1Mahban Group
27 4PharOS Ltd
28 5PharmaPath S.A.
29 4Pharmaline
30 1Pharmapath Sa
31 3Pluviaendo
32 3Prinston
33 8STADA Arzneimittel
34 11Sandoz B2B
35 3Sun Pharmaceutical Industries Limited
36 4Sunshine Lake Pharma
37 2Tecnimede
38 3Varian Pharmed
39 7Viatris
40 6Zentiva
41 4Zydus Pharmaceuticals
01 3Each Coated Tablet
02 81Film Coated Tablet
03 4Film Coated Tablet
04 14Film-Coated Tablet
05 6Immediate Release Tablet
06 1Linagliptin 5Mg 28 Combined Oral Use
07 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
08 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
09 4Oral Solid Dosage Form
10 4TABLET
11 6TABLET, EXTENDED RELEASE;ORAL
12 4TABLET; ORAL
13 38TABLET;ORAL
14 19Tablet
15 2Tablets
16 1Tablets
17 2tablet
18 7Blank
01 5Allowed
02 10Approved
03 18Authorised
04 25Authorized
05 1Dossier Readiness: Q1 2025
06 2Generic
07 4Lead Market Dossiers- Filed
08 6Marketed
09 8Not Marketed
10 18Prescription
11 31RX
12 1Withdrawn
13 69Blank
01 2Autnami
02 1Diagliptin Deo
03 1Drojarto
04 3EMPAGLIFLOZIN AND LINAGLIPTIN
05 6EMPAGLIFLOZIN; LINAGLIPTIN
06 2Empagliflozin ; Linagliptin
07 1Empiria Complex
08 1Empiria Complex
09 2GLYXAMBI
10 2Girl Duet
11 2Glymetia
12 10Glyxambi
13 1Glyxambi
14 2Ilinpru
15 6JENTADUETO
16 2JENTADUETO XR
17 25Jentadueto
18 3Jentadueto mg
19 7LINAGLIPTIN
20 1LINAGLIPTIN 5
21 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
22 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
23 1Liglinra
24 1Linagliptin
25 3Linagliptin ; Metformin Hydrochloride
26 1Linagliptin Accord
27 1Linagliptin Intas
28 1Linagliptin Medochemie5
29 1Linagliptin Medochemistry
30 1Linagliptin Pharos
31 3Linagliptin Sandoz
32 1Linagliptin Stada
33 1Linagliptin Viatris
34 1Linagliptin Zentiva
35 3Linagliptin/Metformin Clonmel
36 3Linagliptin/Metformin Hcl Pharos
37 3Linagliptin/Metformin Sandoz
38 3Linagliptin/Metformin Stada
39 1Linagliptina Alter
40 1Linagliptina Medochemie
41 1Linagliptina Pharmapath
42 1Linagliptina Stada
43 2Linagliptina/Metformina Sandoz
44 2Linagliptine/Metformin Stada
45 1Linathan
46 1Lynxaram
47 2Meglithan
48 1Melijent
49 1Sansik
50 1TRADJENTA
51 1TRAJENTA
52 4TRIJARDY XR
53 1Tingapla
54 9Trajenta
55 6Trajentamet
56 1Zyfoqam
57 33Blank
01 12Australia
02 4Canada
03 4Czech Republic
04 14Estonia
05 3Guatemala
06 14India
07 5Iran
08 3Italy
09 4Latvia
10 4Lebanon
11 19Malta
12 14Norway
13 2Poland
14 5Portugal
15 25Spain
16 10Sweden
17 5Switzerland
18 3Turkey
19 48USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208428
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
